Our data confirmed the ability of CEBPA-DT to regulate CEBPA/BCL2 expression in CDDP-resistant OSCC cells may be by a “lncRNA-mRNA” pattern, suggesting that CEBPA may be a key target of this lncRNA in the context of tumor chemoresistance. The gene discussed is BCL2; the disease is neoplasm.